A detailed history of Campbell & CO Investment Adviser LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 1,043 shares of UTHR stock, worth $396,016. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,043
Holding current value
$396,016
% of portfolio
0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $324,414 - $379,182
1,043 New
1,043 $373,000
Q1 2024

May 10, 2024

SELL
$210.76 - $249.51 $487,487 - $577,116
-2,313 Reduced 28.05%
5,932 $1.36 Million
Q4 2023

Feb 13, 2024

BUY
$214.88 - $256.94 $1.1 Million - $1.32 Million
5,120 Added 163.84%
8,245 $1.81 Million
Q3 2023

Nov 08, 2023

BUY
$211.82 - $248.24 $355,433 - $416,546
1,678 Added 115.96%
3,125 $705,000
Q2 2023

Aug 11, 2023

SELL
$205.19 - $232.99 $1.86 Million - $2.11 Million
-9,071 Reduced 86.24%
1,447 $319,000
Q1 2023

May 11, 2023

BUY
$212.99 - $276.17 $846,422 - $1.1 Million
3,974 Added 60.73%
10,518 $2.36 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $1.35 Million - $1.84 Million
6,544 New
6,544 $1.82 Million
Q2 2022

Aug 09, 2022

BUY
$174.81 - $241.14 $1.07 Million - $1.48 Million
6,127 Added 358.72%
7,835 $1.85 Million
Q1 2022

May 09, 2022

BUY
$166.16 - $213.96 $60,814 - $78,309
366 Added 27.27%
1,708 $306,000
Q4 2021

Feb 10, 2022

SELL
$184.32 - $216.08 $276,480 - $324,120
-1,500 Reduced 52.78%
1,342 $290,000
Q3 2021

Nov 10, 2021

BUY
$179.86 - $214.88 $511,162 - $610,688
2,842 New
2,842 $525,000
Q2 2021

Aug 11, 2021

SELL
$170.47 - $211.93 $220,247 - $273,813
-1,292 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $64,346 - $73,087
-418 Reduced 24.44%
1,292 $216,000
Q4 2020

Feb 09, 2021

SELL
$101.87 - $151.79 $61,122 - $91,074
-600 Reduced 25.97%
1,710 $260,000
Q3 2020

Oct 15, 2020

SELL
$99.9 - $121.13 $235,264 - $285,261
-2,355 Reduced 50.48%
2,310 $233,000
Q2 2020

Jul 29, 2020

BUY
$92.74 - $125.82 $432,632 - $586,950
4,665 New
4,665 $564,000
Q4 2018

Feb 08, 2019

SELL
$101.4 - $128.73 $181,911 - $230,941
-1,794 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$113.81 - $129.46 $204,175 - $232,251
1,794 New
1,794 $229,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.